XML 32 R22.htm IDEA: XBRL DOCUMENT v3.23.1
Stock Compensation (Tables)
3 Months Ended
Mar. 31, 2023
Stock Compensation [Abstract]  
Schedule of non-vested restricted stock awards
   Non-vested
Restricted Stock Awards
 
   Number of
Shares
   Weighted
Average
Grant Date
Fair Value
 
Outstanding at December 31, 2022   60,000   $1.29 
Granted   512,180    0.44 
Vested   (374,680)   0.44 
Forfeited   
-
    
-
 
Outstanding at March 31, 2023   197,500   $0.70 

 

Schedule of stock option activity
   Number of
Stock
Options
   Weighted
Average
Exercise
Price Per
Share
   Weighted
Average
Remaining
Contractual
Life in Years
   Aggregate
Intrinsic
Value
 
Outstanding at December 31, 2022   719,835   $1.96    6.5   $20,578 
Granted   20,000    0.53           
Exercised   
-
    
-
    
-
    
-
 
Cancelled and forfeited   
-
    
-
    
-
    
-
 
Outstanding at March 31, 2023   739,835   $1.92    7.7   $23,316 
Exercisable at March 31, 2023   564,440   $1.86    7.4   $23,316 

 

Schedule of grant-date fair value of share-based awards granted
   Three Months Ended
March 31,
 
   2023   2022 
Risk-free interest rate   3.63%   1.58% - 2.40% 
Expected dividend yield   0.00%   0.00%
Volatility factor   108.78%   102.03% 
Expected life of option (in years)   6.00     5.37 – 6.00 

 

Schedule of stock-based compensation expense
   Three Months Ended
March 31,
 
   2023   2022 
Research and development  $44,845   $17,311 
General and administrative   159,584    108,305 
Sales and marketing   15,160    470 
Total stock-based compensation  $219,589   $126,086